Is There Liability With Chemotherapy Following Immediate Breast Reconstruction?
- 1 April 1996
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic & Reconstructive Surgery
- Vol. 97 (5), 969-973
- https://doi.org/10.1097/00006534-199604001-00013
Abstract
Review of 46 consecutive patients undergoing immediate breast reconstruction with tissue expanders and subsequent implant placement was conducted to assess the potential liability of adjuvant chemotherapy. Twenty-three patients required chemotherapy, while 23 did not. Critical comparison of complications and outcome of the two groups revealed no significant differences. Within the parameters of the study (avoidance of expansion or surgery during the period of chemotherapy), there appeared to be no disadvantage posed to the immediate reconstruction patient by adjuvant chemotherapy. We feel that this option can continue to be offered despite the anticipation of probable chemotherapy.Keywords
This publication has 6 references indexed in Scilit:
- Analysis of Risks and Aesthetics in a Consecutive Series of Tissue Expansion Breast ReconstructionsPlastic and Reconstructive Surgery, 1992
- Sixty Consecutive Breast Reconstructions with the Inflatable ExpanderPlastic and Reconstructive Surgery, 1990
- The complications of tissue expansion in breast reconstruction: a review of 75 casesBritish Journal of Plastic Surgery, 1987
- The Effect of Cigarette Smoking on Skin-Flap Survival in the Face Lift PatientPlastic and Reconstructive Surgery, 1984
- Selective Use of Serial Expansion in Breast ReconstructionAnnals of Plastic Surgery, 1983
- Breast Reconstruction after Mastectomy Using the Temporary ExpanderPlastic and Reconstructive Surgery, 1982